Search
Spotlight
CME Opportunities
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Global Insights on Anti-Angiogenic Therapy for Metastatic Lung Cancer
EP. 1: Dysregulated Angiogenesis in Lung Cancer
November 11th 2016
EP. 2: Targeting Angiogenesis in Non–Small Cell Lung Cancer
November 11th 2016
EP. 3: Bevacizumab in Nonsquamous Lung Cancer
November 11th 2016
EP. 4: Mechanisms of Anti-angiogenic Therapy in Lung Cancer
November 11th 2016
EP. 5: Patient Selection for Ramucirumab in NSCLC
November 11th 2016
EP. 6: Sequencing Therapies in Advanced Lung Adenocarcinoma
November 11th 2016
EP. 7: Blocking VEGFR2 vs VEGFA or VEGFB in Lung Cancer
November 11th 2016
EP. 8: Antiangiogenic Antibodies vs TKIs in NSCLC
November 11th 2016
EP. 9: Resistance to Antiangiogenic Therapy in Lung Cancer
November 11th 2016
EP. 10: Promising Anti-VEGF Combinations for NSCLC
November 11th 2016
NEXT PAGE
<
1
2
>
PREVIOUS PAGE
x